A Study of the Efficacy and Safety of Upadacitinib in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional and/or Biologic Therapies

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The objective of this study is to evaluate the efficacy and safety of upadacitinib compared to placebo as induction therapy in adults with moderately and severely active Crohn\'s disease (CD).
Epistemonikos ID: bab75781ac9b456e2fa64f7a6ae8d127a645395f
First added on: May 21, 2024